Finance News Economic Calendar

Finance
Quartz (News)

News from Quartz

All U.S. UK Canada Australia Europe India Global Crypto

No results found

Type at least 2 characters to search

Loading tags...

No matching tags found

Filter by:

Any time Past hour Past 24 hours Past week Past month Past year

All Sources ABC News Business BBC Business Business Insider Markets City A.M. CNBC Business CoinDesk Coinpedia Cointelegraph Crypto News CryptoSlate Decrypt Economic Times Markets Euronews Business Financial Post Top Stories Financial Times Globe and Mail Investing Investing.com Global Mkts Investopedia Kiplinger MarketWatch MarketPulse MarketWatch Top Stories Quartz Sky News Money Sydney Morning Herald Biz TechCrunch Fintech The Block The Guardian – Business WSJ Markets News

All Access Types Free Limited Free Subscription Required

Category Fda

Source Quartz

Quartz • 02/19/2026 • Limited Free

The FDA could approve key component of magic mushrooms as a depression treatment

The potential FDA approval of Compass Pathways' psilocybin could drive significant market interest and investment in psychedelics as a novel treatment...

Read Full Article →

Quartz • 08/18/2025 • Limited Free

Half-off Ozempic deal sends Novo Nordisk stock surging

The recent approval for Novo Nordisk’s Wegovy drug in liver treatment, combined with a major discount on Ozempic, has led to a notable increase in the...

Read Full Article →

Quartz • 08/11/2025 • Limited Free

FDA biologics chief back 12 days after resigning, creating pressure on biotech stocks

The unexpected return of the FDA biologics leader shortly after stepping down has introduced uncertainty, leading to a decline in the valuation of var...

Read Full Article →

Quartz • 07/16/2025 • Limited Free

Knockoff weight loss drugs were supposed to be 'gone and illegal.' Now they're bigger than ever

Despite regulatory efforts to eliminate counterfeit weight loss medications, compounding pharmacies have found a way to continue production, resulting...

Read Full Article →

Quartz • 07/09/2025 • Limited Free

Biotech startups are facing a new threat

Recent reductions in government support and regulatory challenges have caused investors to become more cautious, potentially limiting financial resour...

Read Full Article →

Price Alerts

Sign in to create alerts

News from Quartz

The FDA could approve key component of magic mushrooms as a depression treatment

Half-off Ozempic deal sends Novo Nordisk stock surging

FDA biologics chief back 12 days after resigning, creating pressure on biotech stocks

Knockoff weight loss drugs were supposed to be 'gone and illegal.' Now they're bigger than ever

Biotech startups are facing a new threat

Featured Sources

What is your interest today?

Sign in to continue

Weekly limit reached

Export limit reached

Historical lookups used

Extended Charts - Pro Feature

Cloud Export - Pro Feature

News from Quartz

The FDA could approve key component of magic mushrooms as a depression treatment

Half-off Ozempic deal sends Novo Nordisk stock surging

FDA biologics chief back 12 days after resigning, creating pressure on biotech stocks

Knockoff weight loss drugs were supposed to be 'gone and illegal.' Now they're bigger than ever

Biotech startups are facing a new threat

Featured Sources

What is your interest today?

Format Settings

Language

Localized Format

Decimal Format